tm
Seeing Is Believing
tm
Seeing Is Believing
BOLD is currently covered by 2 analysts with an average price target of $8.42. This is a potential upside of $6.98 (484.72%) from yesterday's end of day stock price of $1.44.
Audentes Therapeutics's activity chart (see below) currently has 27 price targets and 21 ratings on display. The stock rating distribution of BOLD is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 94.72% with an average time for these price targets to be met of 208 days.
Highest price target for BOLD is $10, Lowest price target is $3, average price target is $20.
Most recent stock forecast was given by DEBJIT CHATTOPADHYAY from GUGGENHEIM on 13-Dec-2024. First documented stock forecast 01-May-2017.
Currently out of the existing stock ratings of BOLD, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$24
4 months 26 days ago
(13-Dec-2024)
7/8 (87.5%)
$13.99 (139.76%)
90
Buy
$20
$18.39 (1142.24%)
1 years 17 days ago
(22-Apr-2024)
9/10 (90%)
$9.99 (99.80%)
264
Buy
$48
5 years 5 months 5 days ago
(04-Dec-2019)
4/4 (100%)
$9.47 (24.58%)
224
Hold
$45
5 years 5 months 6 days ago
(03-Dec-2019)
4/4 (100%)
$8.67 (23.86%)
290
Hold
$57
5 years 5 months 6 days ago
(03-Dec-2019)
2/2 (100%)
$17.02 (43.32%)
468
What is BOLD (Audentes Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BOLD (Audentes Therapeutics) with a proven track record?
Which analyst has the current lower performing score on BOLD (Audentes Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BOLD (Audentes Therapeutics)?
Which analyst is the currently most bullish on BOLD (Audentes Therapeutics)?
Which analyst is the currently most reserved on BOLD (Audentes Therapeutics)?
